Glucovance, a new tablet that combines glyburide and metformin
September 2000
Bristol-Myers Squibb is now marketing Glucovance, a new tablet that combines glyburide and metformin.
Many patients get metformin and a sulfonylurea for diabetes. These drugs have additive effects to lower blood sugar.
The combination can lower HbA1c by 1.5% to 3.5%...depending on the patient's initial HbA1c.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote